MicroRNA-7 Enhances Subventricular Zone Neurogenesis by Inhibiting NLRP3/Caspase-1 Axis in Adult Neural Stem Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-7 Enhances Subventricular Zone Neurogenesis by Inhibiting NLRP3/Caspase-1 Axis in Adult Neural Stem Cells
Authors
Keywords
microRNA-7, Neurogenesis, Neural stem cell, NLRP3 inflammasome, Parkinson’s disease
Journal
MOLECULAR NEUROBIOLOGY
Volume 53, Issue 10, Pages 7057-7069
Publisher
Springer Nature
Online
2015-12-16
DOI
10.1007/s12035-015-9620-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammasomes are Differentially Expressed in Cardiovascular and other Tissues
- (2017) Y. Yin et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- microRNA-7: A tumor suppressor miRNA with therapeutic potential
- (2014) Felicity C. Kalinowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inflammasomes in the CNS
- (2014) John G. Walsh et al. NATURE REVIEWS NEUROSCIENCE
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons
- (2012) Antoine de Chevigny et al. NATURE NEUROSCIENCE
- Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b
- (2011) Xiaokun Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroinflammation in Parkinson's disease
- (2011) Etienne C. Hirsch et al. PARKINSONISM & RELATED DISORDERS
- MicroRNAs in Development and Disease
- (2011) Danish Sayed et al. PHYSIOLOGICAL REVIEWS
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Molecular Mechanism of NLRP3 Inflammasome Activation
- (2010) Chengcheng Jin et al. JOURNAL OF CLINICAL IMMUNOLOGY
- -Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
- (2010) E.-J. Lee et al. JOURNAL OF IMMUNOLOGY
- Ectopic expression of α-synuclein affects the migration of neural stem cells in mouse subventricular zone
- (2010) Momo Tani et al. JOURNAL OF NEUROCHEMISTRY
- The effect of drug treatment on neurogenesis in Parkinson's disease
- (2010) Sean S. O'Sullivan et al. MOVEMENT DISORDERS
- MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
- (2010) A. Baudry et al. SCIENCE
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- Molecular pathogenesis of Parkinson disease: insights from genetic studies
- (2009) Thomas Gasser EXPERT REVIEWS IN MOLECULAR MEDICINE
- MicroRNAs: key regulators of stem cells
- (2009) Vamsi K. Gangaraju et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms involved in inflammasome activation
- (2009) Clare Bryant et al. TRENDS IN CELL BIOLOGY
- AQP4 knockout impairs proliferation, migration and neuronal differentiation of adult neural stem cells
- (2008) H. Kong et al. JOURNAL OF CELL SCIENCE
- Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
- (2008) James B Koprich et al. Journal of Neuroinflammation
- -Synuclein Alters Notch-1 Expression and Neurogenesis in Mouse Embryonic Stem Cells and in the Hippocampus of Transgenic Mice
- (2008) L. Crews et al. JOURNAL OF NEUROSCIENCE
- Requirement of AQP4 for Antidepressive Efficiency of Fluoxetine: Implication in Adult Hippocampal Neurogenesis
- (2008) Hui Kong et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started